stockrowRadNet, Inc.
RDNT Healthcare Diagnostics & Research
RadNet, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.0 billion, up 11.5% from fiscal 2024.
- Revenue
- +25.0%
- EPS
- −47.4%
- Free cash flow
- −43.2%
- Total debt
- +21.2%
Quarter to June 2026, against a year earlier
Follow RDNT
Alert me
RadNet, Inc. (RDNT) Return on invested capital
RadNet, Inc.'s return on invested capital over the twelve months to 30 June 2026 was 2.24%, down 0.1 percentage points from fiscal 2025 (2.31%). Over the past ten years it has ranged from 2.24% (fiscal 2018) to 5.00% (fiscal 2021); the current reading is higher than 27% of that period. That is above the Diagnostics & Research industry median of 0.00% and above the Healthcare sector median of 0.00%.
Return on invested capital, annual
Embed this chart
Annual newest first
| Period | Return on invested capital | Change (points) |
|---|---|---|
| FY2025 | 2.31% | (2.33) |
| FY2024 | 4.64% | (0.17) |
| FY2023 | 4.81% | 2.53 |
| FY2022 | 2.28% | (2.72) |
| FY2021 | 5.00% | 2.46 |
| FY2020 | 2.54% | (2.04) |
| FY2019 | 4.58% | 2.34 |
| FY2018 | 2.24% | (2.74) |
| FY2017 | 4.98% | 1.39 |
| FY2016 | 3.59% | (0.22) |
Against its own ten years
Return on invested capital against peers
| Company | Return on invested capital |
|---|---|
| CDNA CareDx, Inc. compare | 33.6% |
| SHC Sotera Health Company compare | 9.80% |
| QGEN QIAGEN N.V. compare | 6.62% |
| VCYT Veracyte, Inc. compare | 4.33% |
| ICLR ICON PLC compare | 3.84% |
| RDNT RadNet, Inc. | 2.24% |
| ADPT Adaptive Biotechnologies Corporation compare | 0.00% |
| BLLN BillionToOne, Inc. compare | 0.00% |
| GRAL GRAIL, Inc. compare | −14.7% |
| Diagnostics & Research industry median | 0.00% |
| Healthcare sector median | 0.00% |
| Market median | 0.00% |
What Return on invested capital is
Return on Invested Capital shows how much after-tax operating profit a company earns on the money its lenders and shareholders have put in.
TTM: (Operating Income × 0.625) ÷ (Shareholders Equity (Total) (latest quarter) + Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter) − Cash & Short Term Investments (latest quarter)); Annual: (Operating Income × 0.625) ÷ (Shareholders Equity (Total) + Long Term Debt (Total) + Current Part of Debt − Cash & Short Term Investments)
More on RDNT
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement